Why the study?
Multiple next-generation transcatheter heart valves have been developed to minimize procedural complications and improve outcomes, prompting an updated review of these devices and delivery systems.
How do new generation transcatheter heart valves and delivery systems improve procedural complications and clinical outcomes in patients with severe aortic valve stenosis?
How do new generation transcatheter heart valves and delivery systems improve procedural complications and clinical outcomes in patients with severe aortic valve stenosis?
Answers are grounded in this paper and cite their sources.
This review highlights ongoing advancements in transcatheter heart valves that mitigate historical limitations of TAVR such as paravalvular leak and vascular complications.
Over the last 15 years, the management of aortic valve disease has been changed by transcatheter aortic valve replacement, which has become the standard of care across the entire spectrum of surgical risk. As a result of continuous evolution of this technique, several next-generation transcatheter heart valves (THVs) have been developed to minimize procedural complications and improve patient outcomes. This review aims to provide an update on the new generation THVs and delivery systems.
No takes yet. Share an insight, caveat, or question.
Santangelo et al. (2022) conducted a review in Severe aortic valve stenosis. New generation transcatheter heart valves was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: